Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.
Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, Bochennek K, Gruhn B, Lang P, Rohde M, Debatin KM, Steinbach D, Beilken A, Ladenstein R, Spachtholz R, Heiss P, Hellwig D, Tröger A, Koller M, Menhart K, Riemenschneider MJ, Zoubaa S, Kietz S, Jakob M, Sommer G, Heise T, Hundsdörfer P, Kühnle I, Dilloo D, Schönberger S, Schwabe G, von Luettichau I, Graf N, Schlegel PG, Frühwald M, Jorch N, Paulussen M, Schneider DT, Metzler M, Leipold A, Nathrath M, Imschweiler T, Christiansen H, Schmid I, Crazzolara R, Niktoreh N, Cario G, Faber J, Demmert M, Babor F, Fröhlich B, Bielack S, Bernig T, Greil J, Eggert A, Simon T, Foell J. Corbacioglu S, et al. Among authors: frohlich b. Lancet Oncol. 2024 Jul;25(7):922-932. doi: 10.1016/S1470-2045(24)00202-X. Lancet Oncol. 2024. PMID: 38936379 Free article. Clinical Trial.
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification.
Berthold F, Rosswog C, Christiansen H, Frühwald M, Hemstedt N, Klingebiel T, Fröhlich B, Schilling FH, Schmid I, Simon T, Hero B, Fischer M, Ernst A. Berthold F, et al. Among authors: frohlich b. Pediatr Blood Cancer. 2021 Aug;68(8):e29038. doi: 10.1002/pbc.29038. Epub 2021 Apr 7. Pediatr Blood Cancer. 2021. PMID: 33826231
Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma.
Schmid I, Häberle B, Albert MH, Corbacioglu S, Fröhlich B, Graf N, Kammer B, Kontny U, Leuschner I, Scheel-Walter HG, Scheurlen W, Werner S, Wiesel T, von Schweinitz D. Schmid I, et al. Among authors: frohlich b. Pediatr Blood Cancer. 2012 Apr;58(4):539-44. doi: 10.1002/pbc.23295. Epub 2011 Sep 15. Pediatr Blood Cancer. 2012. PMID: 21922643 Clinical Trial.
Ewing tumour: incidence, prognosis and treatment options.
Paulussen M, Fröhlich B, Jürgens H. Paulussen M, et al. Among authors: frohlich b. Paediatr Drugs. 2001;3(12):899-913. doi: 10.2165/00128072-200103120-00003. Paediatr Drugs. 2001. PMID: 11772151 Review.
Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology.
Calaminus G, Schneider DT, von Schweinitz D, Jürgens H, Infed N, Schönberger S, Olson TA, Albers P, Vokuhl C, Stein R, Looijenga L, Sehouli J, Metzelder M, Claviez A, Dworzak M, Eggert A, Fröhlich B, Gerber NU, Kratz CP, Faber J, Klingebiel T, Harms D, Göbel U. Calaminus G, et al. Among authors: frohlich b. Cancers (Basel). 2020 Mar 6;12(3):611. doi: 10.3390/cancers12030611. Cancers (Basel). 2020. PMID: 32155835 Free PMC article.
Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol.
Koscielniak E, Blank B, Vokuhl C, Kazanowska B, Ladenstein R, Niggli F, Ljungman G, Handgretinger R, Seitz G, Fuchs J, Fröhlich B, Scheer M, Wessalowski R, Schmid I, Sparber-Sauer M, Klingebiel T. Koscielniak E, et al. Among authors: frohlich b. Cancers (Basel). 2022 Feb 11;14(4):899. doi: 10.3390/cancers14040899. Cancers (Basel). 2022. PMID: 35205646 Free PMC article.
139 results